Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TYR | P14679 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | AR | P10275 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | ESRRG | P62508 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7929288 | 0.92 | KIF11 (0.58) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7937287 | 0.87 | ESR1 (0.76) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7937977 | 0.85 | ESR1 (0.64) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7940616 | 0.85 | ESR1 (0.64) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7938430 | 0.85 | NR1H2 (0.64) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL8067180 | 0.83 | ESR1 (0.78) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7938509 | 0.83 | ESR1 (0.39) | ESR1ESR2CYP3A4TSHRLMNA | |
| SCHEMBL7929201 | 0.83 | LMNA (0.65) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL9816151 | 0.83 | TSHR (0.67) | CYP3A4TSHRLMNAMEN1KMT2A | |
| SCHEMBL545084 | 0.83 | TSHR (0.67) | CYP3A4TSHRLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114583088-A | Quantum dot light-emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2022111583-A1 | QUANTUM DOT LIGHT-EMITTING DIODE AND PREPARATION METHOD THEREFOR | TCL科技集团股份有限公司 | 2022-06-02 | — | — | WO | claimed |
| US-5071812-A | Catalyst comprising the reaction product of a tungsten or molybdenum salt and a borohydride | SHELL OIL COMPANY (US) | 1991-12-10 | — | — | US | claimed |
| US-5028672-A | Catalyst and process for polymerization of norbornene derivatives | SHELL OIL COMPANY (US) | 1991-07-02 | — | — | US | claimed |
| US-4994426-A | Catalyst and process for polymerization of norbornene derivatives | SHELL OIL COMPANY (US) | 1991-02-19 | — | — | US | claimed |
| EP-0336486-A2 | Polymerization of norbornene derivatives and catalytic system suitable for use therein | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-10-11 | — | — | EP | claimed |
| JP-57051808-A | — | — | None | — | — | JP | disclosed |
| CN-118326070-A | Rapid detection method for rape black shank based on RPA-Cas12a | 华中农业大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118291443-A | Geotrichum candidum DNA extraction process | 德州市荣光生物科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-12018275-B2 | Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy | THE BROAD INSTITUTE, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240200118-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING TROPISM OF DELIVERY SYSTEMS FOR RNA | RENAGADE THERAPEUTICS MANAGEMENT INC. | 2024-06-20 | — | — | US | disclosed |
| US-11999948-B2 | Methods of producing size-selected nucleic acid libraries and compositions and kits for practicing same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-04 | — | — | US | disclosed |
| EP-4337774-A1 | PROGRAMMABLE NANOENCAPSULATION FOR DELIVERY OF PROBIOTICS IN VIVO | The Trustees of Columbia University in the City of New York (US) | 2024-03-20 | — | — | EP | disclosed |
| US-4252662-A | EROSION INHIBITOR | STAUFFER CHEMICAL COMPANY (US) | 1981-02-24 | — | — | US | disclosed |
| EP-0016450-A1 | Synthetic fur and process for preparation thereof | TEIJIN LIMITED (JP) | 1980-10-01 | — | — | EP | disclosed |
| EP-0004447-A2 | Preparation of trifluoromethylphenols and novel trifluoromethylphenyl benzyl ether intermediates | ELI LILLY AND COMPANY (US) | 1979-10-03 | — | — | EP | disclosed |
| US-4168388-A | Trifluoromethylphenyl benzyl ethers | ELI LILLY AND COMPANY (US) | 1979-09-18 | — | — | US | disclosed |
| US-4046656-A | Photochlorination process for methyl aromatic compounds | THE DOW CHEMICAL COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3956154-A | AIRCRAFT | STAUFFER CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| JP-S05751808-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240200118-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING TROPISM OF DELIVERY SYSTEMS FOR RNA | NSUN3, PHAX, RNGTT | ESR1 1931/4885ESR2 2193/4885CYP3A4 4844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.